Annual report pursuant to Section 13 and 15(d)

Note 14 - Stockholders' Equity - Summary of Warrants (Details)

v3.22.0.1
Note 14 - Stockholders' Equity - Summary of Warrants (Details)
 12 Months Ended
Nov. 30, 2021
$ / shares
shares
Nov. 30, 2020
$ / shares
shares
Outstanding, number of warrants (in shares) | shares 585,739 4,578,722
Outstanding, weighted average exercise price (in dollars per share) $ 2.40 $ 2.20
Granted, number of warrants (in shares) | shares 0 214,684
Granted, weighted average exercise price (in dollars per share) $ 0 $ 2.50
Exercised, number of warrants (in shares) | shares (585,739) (4,207,667)
Exercised, weighted average exercise price (in dollars per share) $ 2.40 $ (2.10)
Exercised, weighted average exercise price (in dollars per share) $ (2.40) $ 2.10
Outstanding, number of warrants (in shares) | shares 0 585,739
Outstanding, weighted average exercise price (in dollars per share) $ 0 $ 2.40
Exercisable, number of warrants (in shares) | shares 0 585,739
Exercisable, weighted average exercise price (in dollars per share) $ 0 $ 2.40
Total outstanding warrants, weighted-average remaining contract lives (Year)   2 years 9 months 25 days
Total exercisable warrants, weighted-average remaining contract lives (Year)   2 years 9 months 25 days